Differentiation of human placental BeWo cells by the environmental contaminant benzo(a)pyrene.

Article Details

Citation
Copy to clipboard

Le Vee M, Kolasa E, Jouan E, Collet N, Fardel O

Differentiation of human placental BeWo cells by the environmental contaminant benzo(a)pyrene.

Chem Biol Interact. 2014 Mar 5;210:1-11. doi: 10.1016/j.cbi.2013.12.004. Epub 2013 Dec 17.

PubMed ID
24361490 [ View in PubMed
]
Abstract

Polycyclic aromatic hydrocarbons (PAHs) such as benzo(a)pyrene (BaP) are widely-distributed environmental contaminants known to exert toxic effects in various tissues, including placenta. PAHs have notably been shown to inhibit proliferation of trophoblastic cells. The present study was designed to determine whether PAHs can concomitantly affect differentiated functions of trophoblastic cells. BaP was found to induce expression and secretion of beta-human chorionic gonadotropin (beta-hCG) in human trophoblastic BeWo cells. The PAH also increased mRNA expressions of other trophoblastic differentiation markers, including those of the steroid metabolism enzymes CYP19A1 and HSD11B2 and of the fusogenic protein syncytin-2; in parallel, it triggered syncytialisation of BeWo cells. BaP-mediated beta-hCG and syncytin-2 up-regulation was prevented by co-treatment by the aryl hydrocarbon receptor (AhR) antagonist CH-223191 or by knocking-down AhR expression through siRNA transfection. However, the potent AhR agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) failed to induce expression of beta-hCG and syncytin-2, indicating that activation of the AhR pathway, known to be implicated in most, if not all, effects of PAHs, was required, but not sufficient. Interestingly, the p53 signaling pathway was activated by BaP, but not by TCDD, in BeWo cells and co-treatment by the p53 inhibitor pifithrin-alpha or siRNAs-mediated silencing of p53 prevented up-regulation of beta-hCG and syncytin-2 induced by BaP. Taken together, these data demonstrate that BaP induces differentiation of placental trophoblastic BeWo cells in an AhR- and p53-dependent manner.